| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K07442505 |
| PharmacoGx | BRD-K07442505 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CENPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | EPPK1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | SDR16C5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GDPD5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SLC25A18 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MFSD5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | DNAJB13 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CDC20 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FAM174A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
